In a world where longevity is a sought-after goal, the prospect of South Korean women becoming the first in history to surpass 90 years of age by 2030 is nothing short of extraordinary. This isn't just a statistical prediction; it's a testament to the power of healthcare, socioeconomic improvement, and equitable access. But what makes this story truly fascinating is the rapidity and equity with which South Korea has achieved this milestone. Personally, I think this is a story that demands a closer look, not just at the numbers, but at the policies, behaviors, and cultural shifts that have made this possible. What makes this particularly fascinating is the contrast between South Korea and the United States, two wealthy industrialised democracies with vastly different healthcare systems and societal structures. While the US is projected to fall behind, South Korea has managed to distribute its health improvements broadly across its population, with a focus on equity and access. This raises a deeper question: what can the world learn from South Korea's success in achieving such longevity gains? In my opinion, the answer lies in the country's commitment to healthcare access and socioeconomic improvement, with a focus on equity and consistency. The Lancet study, led by Majid Ezzati, highlights the key factors driving South Korea's exceptional longevity gains, including improvements in childhood nutrition, widespread access to healthcare, relatively low rates of obesity, and equitable distribution of these improvements across socioeconomic classes. This is a stark contrast to the US, where obesity, high maternal and infant mortality rates, unequal access to healthcare, and high homicide rates are holding the country back. The shift in South Korean longevity is, by historical standards, extraordinarily rapid. From 73.4 years in 1985 to 84.2 years in 2010, and now projected to reach 90.8 years by 2030, South Korea has made remarkable strides in just a single generation. This rapid progress is driven by a transition from reductions in infectious disease mortality to the postponement of deaths from non-communicable chronic diseases. What this really suggests is that South Korea has managed to address the root causes of mortality, and is now reaping the rewards of its investments in healthcare and public health infrastructure. The 90-year threshold, once considered nearly insurmountable, is now within reach. This has significant implications for healthcare, retirement, and social policy. A national population with women living to an average of 90 years has a fundamentally different demographic structure from one with women living to 80. The proportion of the population over 80, the duration of retirement, the demands on healthcare and elder-care systems, the labour-force participation rates of older adults, and the inter-generational economic transfers all shift substantially. South Korea, with its rapidly ageing population and one of the world's lowest fertility rates, was already grappling with these issues before the 2017 projection. Since the projection, South Korea has continued to age, and the trajectory can be partially evaluated against actual data. The most recent World Health Organization figures show South Korean female life expectancy at approximately 86.7 years in 2024, already at the level that, in 2012, was the highest in the world. The trajectory has been somewhat disrupted by the COVID-19 pandemic, but South Korea handled the pandemic relatively well in mortality terms. Whether the 90-year threshold is crossed exactly by 2030, or a year or two earlier or later, depends on continued trends in chronic disease mortality among elderly South Korean women. The broader implication of the Lancet study has held up well in the years since publication. South Korea remains the most likely first nation to cross the 90-year average-female-life-expectancy threshold. France, Japan, Spain, and Switzerland remain in the next tier, with their own projections in the upper 80s. The United States has continued to fall behind its peer group in life expectancy gains, with widening internal inequalities and the additional negative impact of the opioid crisis. The basic Ezzati framework — that broad-based socioeconomic equity, healthcare access, and modest population-level differences in BMI and blood pressure can produce dramatic national differences in longevity at the top end of human lifespan — has been substantially validated by the years since 2017. The 90-year threshold, which seemed nearly insurmountable when first projected, is now within a few years of being crossed. This story is not just about numbers; it's about the power of healthcare, socioeconomic improvement, and equitable access. It's a story that challenges us to think about the future of healthcare, retirement, and social policy, and to consider the role of equity and consistency in achieving longevity gains. From my perspective, the implications of this story are far-reaching, and they demand a closer look at the policies, behaviors, and cultural shifts that have made this possible.
